Benzinga | Mar 30, 2021 06:59AM EDT

BD Announces FDA Emergency Use Authorization For Combination COVID-19, Flu Rapid Antigen Test

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for a new, rapid antigen test that can detect SARS-CoV-2, influenza A and influenza B in a single test.